San Antonio, TX, United States of America

Chandra Ulagaraj Singh

This inventor holds 17 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Formulations. Top assignees: Trinity Laboratories Inc., Luminus Biosciences, Inc., Azaya Therapeutics, Inc.. Active years: 1994-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chandra Ulagaraj Singh. Retrieved from https://idiyas.com/inventor/chandra-ulagaraj-singh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 70.6



Average Co-Inventor Count = 1.4

ph-index = 10

Forward Citations = 535(Granted Patents)


Location History:

  • Encinitas, CA (US) (1994 - 1997)
  • San Antonio, TX (US) (1996 - 2019)

Company Filing History:


Years Active: 1994-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Chronic Pain Treatment
Nanoparticle Formulation
Capsaicin Esters
Dextromethorphan Hydrochloride
Drug Design
Liposomal Formulations
Sandalwood Oil Derivatives
Neuropathy Therapy
Premature Ejaculation
Nerium Extract
17 patents (USPTO):Explore Patents

Title: Chandra Ulagaraj Singh: Innovator in Pharmaceutical Compositions

Introduction

Chandra Ulagaraj Singh is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmacology, particularly in the development of pharmaceutical compositions aimed at treating chronic pain and neuropathic pain. With a total of 17 patents to his name, Singh's work has the potential to impact many lives.

Latest Patents

Singh's latest patents include innovative methods and compositions for treating chronic pain and pain associated with neuropathy. One of his notable inventions provides compositions that include dextromethorphan, tramadol, and gabapentin, which can synergistically act to reduce pain in human patients. Additionally, he has developed a solid nanoparticle formulation of water-insoluble pharmaceutical substances, such as docetaxel, which addresses the issue of Ostwald ripening in pharmaceutical compositions.

Career Highlights

Throughout his career, Singh has worked with various companies, including Trinity Laboratories Inc. His expertise in pharmacology and medicinal chemistry has allowed him to create groundbreaking solutions for pain management.

Collaborations

Singh has collaborated with several professionals in his field, including Jagaveerabhadra Rao Nulu and Vitukudi Narayanaiyengar Balaji. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Chandra Ulagaraj Singh is a prominent inventor whose work in pharmaceutical compositions is paving the way for new treatments in pain management. His contributions are significant and continue to influence the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…